02 May 2003
Poly(ADP-ribosyl)ation, DNA repair and life span
A. Bürkle, S. Beneke, C. Brabeck, A. Leake, R. Meyer, M. L. Muiras, R. PfeifferMed Sci Monit 2003; 9(1): 5-0 :: ID: 14990
Abstract
Poly(ADP-ribosyl)ation is functionally associated with DNA base-excision repair and is a survival factor and negative regulator of genomic instability in cells under low to moderate levels of genotoxic stress [1]. Previously we have described a positive correlation between poly(ADP-ribosyl)ation capacity of mononuclear blood cells with longevity of mammalian species [2]. Our subsequent comparisons of purified recombinant human and rat PARP-1 revealed that this correlation might be explained in part by evolutionary sequence divergence [3]. We have also reported an association of high poly(ADP-ribosyl)ation capacity of lymphoblastoid cell cultures with longevity of human donors [4]. Recently we have asked if the efficiency of single strand-break repair in mononuclear blood cells following gamma-radiation might also be related with mammalian life span. We quantified DNA strand breaks both immediately after irradiation and after a defined postincubation (‘repair’) period, using a recently developed automated version of the fluorescence-detected alkaline unwinding assay. Our data reveal the existence of a highly significant positive correlation between the extent of repair and life span of donor species [5]. In another set of experiments we have investigated the possible effects of L-selegiline on the cellular poly(ADP-ribosyl)ation response. L-selegiline is an anti-Parkinson drug, which irreversibly inhibits monoamine oxidase B (MAO-B) but possesses additional effects, such as neuroprotective activity in vivo and in cultured cells and life span-extension in laboratory animals. Intriguingly, our data show that low concentrations of L-selegiline can potentiate the gamma-radiation-induced poly(ADP-ribose) formation in cultured hamster cells [6], thus strengthening the links between poly(ADP-ribosyl)ation, cytoprotection and mammalian longevity.References: 1.Bürkle A: Cancer Lett, 2001; 163: 1-5 2.Grube K, Bürkle A: Proc Natl Acad Sci USA, 1992; 89: 11759-11763 3.Beneke S, Alvarez-Gonzalez R, Bürkle A: Exp Gerontol, 2000; 35: 989-1002 4.Muiras ML, Müller M, Schächter F, Bürkle A: J Mol Med, 1998; 76: 346-354 5.Pfeiffer R, Leake A, Müller M, Kirkwood TB, Bürkle A: manuscript in preparation. 6.Brabeck C, Pfeiffer R, Leake L, Beneke S, Meyer R, Bürkle A: submitted.
Keywords: PARP-1, DNA strand breaks, DNA Repair, ageing, life span, L-selegiline
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952